- CA$9.44m
- CA$9.92m
- CA$5.08m
- 51
- 30
- 33
- 31
Annual income statement for Reklaim, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.178 | 1 | 2.36 | 4.11 | 5.08 |
| Cost of Revenue | |||||
| Gross Profit | -0.214 | -0.439 | -0.131 | 3.18 | 4.16 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.51 | 7.33 | 6.55 | 3.61 | 4.74 |
| Operating Profit | -4.33 | -6.33 | -4.19 | 0.5 | 0.338 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.33 | -6.32 | -4.19 | 0.91 | 0.388 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.33 | -6.32 | -4.19 | 0.91 | 0.373 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.65 | -6.32 | -4.19 | 0.91 | 0.373 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.65 | -6.32 | -4.19 | 0.91 | 0.373 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.1 | -0.106 | -0.058 | 0.009 | 0.003 |